KR100446482B1 - 상피흡착성락토바실러스 - Google Patents

상피흡착성락토바실러스 Download PDF

Info

Publication number
KR100446482B1
KR100446482B1 KR1019970706504A KR19970706504A KR100446482B1 KR 100446482 B1 KR100446482 B1 KR 100446482B1 KR 1019970706504 A KR1019970706504 A KR 1019970706504A KR 19970706504 A KR19970706504 A KR 19970706504A KR 100446482 B1 KR100446482 B1 KR 100446482B1
Authority
KR
South Korea
Prior art keywords
mannose
pharmaceutical composition
specific
lactobacillus
adsorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019970706504A
Other languages
English (en)
Korean (ko)
Other versions
KR19980703102A (ko
Inventor
인게레르트 아델베르트
시브 아르느
벤그트 제프슨
마리-루이즈 조안슨
괴란 모린
앙긴스 울트
Original Assignee
프로비 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프로비 에이비 filed Critical 프로비 에이비
Publication of KR19980703102A publication Critical patent/KR19980703102A/ko
Application granted granted Critical
Publication of KR100446482B1 publication Critical patent/KR100446482B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Adhesives Or Adhesive Processes (AREA)
KR1019970706504A 1995-03-23 1996-03-25 상피흡착성락토바실러스 Expired - Lifetime KR100446482B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501056-7 1995-03-23
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli

Publications (2)

Publication Number Publication Date
KR19980703102A KR19980703102A (ko) 1998-10-15
KR100446482B1 true KR100446482B1 (ko) 2006-01-27

Family

ID=20397666

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970706504A Expired - Lifetime KR100446482B1 (ko) 1995-03-23 1996-03-25 상피흡착성락토바실러스

Country Status (16)

Country Link
US (1) US6159465A (https=)
EP (1) EP0817640B1 (https=)
JP (1) JP4072646B2 (https=)
KR (1) KR100446482B1 (https=)
CN (1) CN1138551C (https=)
AT (1) ATE240738T1 (https=)
AU (1) AU702705B2 (https=)
BR (1) BR9607538A (https=)
CA (1) CA2216150C (https=)
DE (1) DE69628288T2 (https=)
EE (1) EE04097B1 (https=)
ES (1) ES2200057T3 (https=)
NO (1) NO974371L (https=)
PL (1) PL184037B1 (https=)
SE (1) SE9501056D0 (https=)
WO (1) WO1996029083A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
ES2168785T5 (es) * 1997-07-05 2009-04-16 Societe Des Produits Nestle S.A. Absorcion de minerales por las celulas intestinales.
FI974643A7 (fi) * 1997-12-30 1999-07-01 Suomen Rehu Oy Biologinen menetelmä salmonellan eliminoimiseksi prosesseista ja rakenteista
KR20010075495A (ko) * 1998-10-01 2001-08-09 추후보정 산화성 스트레스 인자의 감소
WO2001010448A1 (en) * 1999-08-09 2001-02-15 University Of Maryland, Baltimore Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
MXPA02004115A (es) 1999-10-26 2002-10-17 Nestle Sa Bacterias acidolacticas para el tratamiento o profilaxis de giardiasis.
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
SE0004124D0 (sv) * 2000-11-10 2000-11-10 Probi Ab New use
FR2831555A1 (fr) * 2001-10-29 2003-05-02 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes
FR2826020B1 (fr) * 2001-06-14 2005-02-11 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes
PL364429A1 (en) * 2001-06-14 2004-12-13 Ceva Sante Animale Method of selecting non-pathogenic gram-positive lactic acid bacteria strains
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2005086870A2 (en) * 2004-03-10 2005-09-22 The Board Of Trustees Of The University Of Illinois Novel lactobacillus strains and method of use
JP2007530034A (ja) * 2004-03-23 2007-11-01 エヌ．ブイ．・ヌートリシア 新規のマンノース特異的アドヘシンとその使用
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
JP2006180836A (ja) * 2004-12-28 2006-07-13 Marudai Food Co Ltd 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物
JP2006257077A (ja) * 2005-02-18 2006-09-28 Marudai Food Co Ltd 免疫調節剤および免疫調節食品
CN1888051B (zh) * 2005-06-28 2010-05-05 北京天佑达生物工程科技有限公司 一株植物乳杆菌及其应用
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
DK3067057T3 (da) * 2005-09-28 2023-02-13 Nordic Rebalance As Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier
DK1960016T3 (en) 2005-12-13 2017-01-09 Exthera Medical Corp Method for extracorporeal removal by a pathogenic MI-KROBE, an inflammatory cell or inflammatory protein from the blood.
PL210465B1 (pl) 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
FR2928935B1 (fr) 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
EP2459203B1 (en) * 2009-07-30 2018-10-31 DuPont Nutrition Biosciences ApS Lactic acid bacteria and bifidobacteria for treating endotoxemia
EP2509604B1 (en) 2009-12-01 2021-03-17 ExThera Medical Corporation Device for removing cytokines from blood with surface immobilized polysaccharides
ES2437940T3 (es) 2010-01-28 2014-01-15 Ab-Biotics S.A. Composición probiótica para uso en el tratamiento de la inflamación del intestino
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
BG66608B1 (bg) * 2011-05-04 2017-10-16 "Ел Би Булгарикум" ЕАД Полибактериален пробиотичен препарат
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
JP2012184261A (ja) * 2012-06-21 2012-09-27 Snow Brand Milk Products Co Ltd 免疫増強剤
CN102827796B (zh) * 2012-09-03 2013-10-30 江南大学 一种具有排镉功能的植物乳杆菌及其用途
EP2897638A1 (en) 2012-09-24 2015-07-29 Montana State University-Bozeman Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use
MX376935B (es) 2013-06-24 2025-03-07 Exthera Medical Corp Sistema de filtración de sangre que contiene substrato recubierto con manosa.
CA2928866C (en) 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
AU2015250107A1 (en) 2014-04-24 2016-11-17 Exthera Medical Corporation Method for removing bacteria from blood using high flow rate
CA2959975A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
KR102587444B1 (ko) 2015-09-29 2023-10-11 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승 조성물
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
MX389431B (es) 2017-02-28 2025-03-20 Kimberly Clark Co Composicion sinergica para el mantenimiento del equilibrio saludable de la microflora.
KR102024883B1 (ko) 2017-11-24 2019-09-24 주식회사 고바이오랩 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도
SG10202112104UA (en) 2018-05-09 2021-12-30 Ko Biolabs Inc Lactobacillus paracasei strain and use thereof
AU2019274351B2 (en) 2018-05-23 2022-04-07 Kobiolabs, Inc. Lactobacillus gasseri KBL697 strain and use thereof
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure
CN114007434A (zh) 2019-06-05 2022-02-01 森永乳业株式会社 营养组合物
CN111575223B (zh) * 2020-05-20 2022-04-15 江南大学 一种降低鼠李糖乳杆菌表面物质分泌量的方法
CN119242500A (zh) * 2024-09-30 2025-01-03 尚品健康科技(青岛)有限公司 一株母乳来源植物乳植杆菌改善过敏性疾病和调节肠道菌群的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001823A1 (en) * 1991-07-25 1993-02-04 Probi Ab Intestine colonizing lactobacilli

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR861387B (en) * 1985-05-29 1986-10-02 Pioneer Hi Bred Int Method of treating gastrointestinal disease in animals
GB9124249D0 (en) * 1991-11-14 1992-01-08 Goldstein Fredric Ribbon curling and shredding device
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001823A1 (en) * 1991-07-25 1993-02-04 Probi Ab Intestine colonizing lactobacilli

Also Published As

Publication number Publication date
US6159465A (en) 2000-12-12
JPH11502703A (ja) 1999-03-09
DE69628288D1 (de) 2003-06-26
DE69628288T2 (de) 2004-04-08
KR19980703102A (ko) 1998-10-15
ES2200057T3 (es) 2004-03-01
CA2216150C (en) 2008-01-22
PL322550A1 (en) 1998-02-02
SE9501056D0 (sv) 1995-03-23
CN1185111A (zh) 1998-06-17
EP0817640B1 (en) 2003-05-21
HK1017989A1 (en) 1999-12-10
ATE240738T1 (de) 2003-06-15
CA2216150A1 (en) 1996-09-26
JP4072646B2 (ja) 2008-04-09
NO974371D0 (no) 1997-09-22
EE04097B1 (et) 2003-08-15
EE9700329A (et) 1998-06-15
AU5166596A (en) 1996-10-08
EP0817640A1 (en) 1998-01-14
WO1996029083A1 (en) 1996-09-26
CN1138551C (zh) 2004-02-18
AU702705B2 (en) 1999-03-04
BR9607538A (pt) 1998-01-06
PL184037B1 (pl) 2002-08-30
NO974371L (no) 1997-11-20

Similar Documents

Publication Publication Date Title
KR100446482B1 (ko) 상피흡착성락토바실러스
EP0760848B1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
EP0199535B1 (en) Lactobacillus acidophilus strains of bacteria and compositions thereof
AU673525B2 (en) Lactic acid bacterium
EP1005353B1 (en) Pharmaceutical preparation comprising lactobacillus casei rhamnosus
Reid In vitro testing of Lactobacillus acidophilus NCFMTM as a possible probiotic for the urogenital tract
HK1000143B (zh) 乳酸細菌
CN103748213A (zh) 益生菌株和用于婴儿食品的包含该益生菌株的共生组合物
Murphy In vivo assessment of potential probiotic Lactobacillus salivarius strains: evaluation of their establishment, persistence, and localisation in the murine gastrointestinal tract
KR20220007660A (ko) 프럭토필릭 락트산 생산 박테리아
EP3035945B1 (en) A probiotic composition comprising the novel isolated bacterial strain of brevibacterium casei ap9
Gibson et al. Recovery of a probiotic organism from human faeces after oral dosing
Chung et al. The effects of Bifidobacterium bifidum OFR9, a strain resistant to antituberculosis and antileprosy agents, on fecal flora in mice
CN121406534A (zh) 一株具有缓解腹泻的乳双歧杆菌bl-pg-09菌株及其制备方法
FI95193C (fi) Uusi Lactobacillus acidophilus-kanta ja sen käyttö elintarvikkeiden, erityisesti meijerituotteiden valmistamiseen
CN121427738A (zh) 一种改善婴幼儿功能性便秘的植物乳植杆菌lp-z6及其应用
HK1017989B (zh) 上皮粘附性乳杆菌
Mubaruk et al. Effect of Lactobacillus Bacteria on the Growth of Escherichia coli Isolated from Infants with Amoebic Dysentery Infections
Macfarlane et al. and Biofilms in the Large Bowel

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19970919

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20010316

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20030729

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20040628

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20040821

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20040823

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20070727

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20080807

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20090811

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20100819

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20110811

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20120725

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20120725

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20130808

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20130808

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20140813

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20140813

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20150817

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20150817

Start annual number: 12

End annual number: 12

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20160925

Termination category: Expiration of duration